Joachim Drevs und Clemens - Info zur Person

(1 - 6 von 7

)

Metronomic Antiangiogenic Therapy with Capecitabine and ...

www.karger.com

von S Steinbild · · Zitiert von: 81 — ... Arends Michael Medinger Brigitte Häring Annette Frost Joachim Drevs Clemens Unger Ralph Strecker Jürgen Hennig Klaus Mross Tumor Biology ... › Abstract

Zusatzinformationen: Tumor Angiogenesis | Ilmenauer Discovery Tool

find.bibliothek.tu-ilmenau.de

... Clinical Development of the VEGFR Signalling Inhibitor AZD Joachim Drevs and Clemens Unger ; Clinical Development of Sunitinib Malate / Isan Chen, ...

Clinical Development of the VEGFR Signalling Inhibitor ...

link.springer.com

von J Drevs · — Clinical Development of the VEGFR Signalling Inhibitor AZD Authors; Authors and affiliations. Joachim Drevs; Clemens Unger. Joachim Drevs. › chapter

A Phase IA, Open-label, Dose-escalating Study of PTK787/ZK ...

ar.iiarjournals.org

von J DREVS · · Zitiert von: 9 — JOACHIM DREVS, MICHAEL MEDINGER, KLAUS MROSS, STEFAN FUXIUS, JUERGEN HENNIG, MARTIN BUECHERT, ANNE THOMAS, CLEMENS UNGER, BEE-LIAN CHEN, DAVID LEBWOHL and ... › content

Effects of PTK787/ZK , a Specific Inhibitor of Vascular ...

aacrjournals.org

Joachim Drevs, Inga Hofmann, Harald Hugenschmidt, Christine Wittig, Helmut Madjar, Marianne Müller, Jeanette Wood, Georg Martiny-Baron, Clemens Unger, ... › article › E...